BCL2L12 and acute myeloid leukemia: The current study included 87 newly diagnosed adult AML patients with age ranged from 20 to 70 years, out of which,75 patients were evaluated for both LCN and BCL2L12, and all 87 patients were evaluated for LCN, together with twenty age and sex matched healthy controls.